Digestive Health & Clinical NutritionMetabolic Arthropathy & Diet
Gout and Hyperuricemia: Uric Acid Causes, Flare-Up Relief, and Low-Purine Diet
Gout is a severely painful crystalline arthropathy caused by MSU crystal deposition in synovial joints and tissues. Explore the metabolic processes involved in purine metabolism, factors that cause hyperuricemia (>6.8 mg/dL), agents used to treat acute attacks (Colchicine/NSAID). And long-term therapy using Urate Lowering drug (Allopurinol) to target levels.
R
Written by Dr. Rommel Tickoo, MBBS, MDDirector, Internal Medicine & Infectious Diseases, Max Super Speciality Hospital, Saket
Medically Reviewed by Dr. Randhir Sud, MBBS, MD, DM, MAMS✓ Verified
Published: 2026-08-21Reviewed: October 2026Updated: 2026-11-03T13:00:51.286Z 10 min read 4520 Views
Listen to this guide Audio Edition
Hands-free audio narration
Educational Health Notice
This educational guide is researched in accordance with our Editorial Policy and public health guidelines. It is not personal medical advice. For clinical questions, read our Medical Disclaimer or consult a qualified healthcare provider.
Quick Summary & Key Findings
Gout attacks occur due to excessive levels of uric acid in the serum (>6.8mg/dL) leading to deposition of needle like urate crystals in the joints (typically first toe / Podagra). Acute attacks can be managed using Colchicine, NSAIDS or Glucocorticoids. Urate lowering therapy should be used to prevent future attacks with Allopurinol or Febuxostat to keep Uric Acid <6.0mg/dL.
Gout is one of the most painful types of inflammatory arthritis seen in rheumatology and internal medicine. It was once considered a quirky disease caused by overindulgence in royalty but is now understood to be a complex metabolic condition.
Humans cannot produce functioning uricase due to evolutionary changes in the UOX gene. This means that the end metabolite of purines is uric acid. If serum uric acid levels are above the physiological saturation point (6.8mg/dL/404umol/L), monosodium urate will become supersaturated and form sharp needle-like crystals in peripheral joints that are cooler than normal body temperature. The most famous joint this occurs in is the first metatarsophalangeal joint (Podagra).
Gout can be effectively managed by recognising the difference between acute management and long-term management to reduce overall crystal load in the body.
Biochemistry & The NLRP3 Inflammasome Immune Cascade
The inflammatory cascade of acute gout includes:
1. Formation of urate crystals: Serum urate levels >6.8mg/dL crystallize to form needle-like monosodium urate (MSU) crystals within avascular or cooler regions of distal joint cartilage.
2. Activation of NLRP3 inflammasome: Phagocytosis of MSU crystals by resident macrophages causes the activation of the intracellular NLRP3 inflammasome complex causing Caspase-1 activation.
3. Production of Interleukin-1 beta (IL-1B): Pro-inflammatory cytokine IL-1B is released in large amounts locally. This causes recruitment of thousands of neutrophils into the synovial fluid.
4. Infiltration of neutrophils to synovium: Neutrophils release reactive oxygen species and lysosomal enzymes causing severe redness, oedema, warmth and severe pain.
Definitive diagnosis: Arthrocentesis (joint aspiration) showing negatively birefringent needle-shaped crystals under polarized light microscopy
Podagra (first metatarsophalangeal joint of the big toe) is the initial presenting site in >50% of first acute flares
Chronic unmanaged gout leads to tophi (chalky, destructive crystal deposits in ears, fingers, elbows, and Achilles tendons)
Over 90% of hyperuricemia cases are caused by renal underexcretion of uric acid (URAT1 / GLUT9 transporter dysfunction) rather than metabolic overproduction
Pharmacological Management: Acute Flares vs. Chronic Prevention
| Therapeutic Phase | Primary Medications | Clinical Mechanism | Treatment Goals & Rules |
|---|---|---|---|
| Acute Flare Abortive Therapy | Colchicine (Colcrys), High-Dose NSAIDs (Indomethacin, Naproxen), Prednisone | Blocks microtubule assembly in neutrophils (Colchicine); inhibits COX enzymes and cytokines. | Initiate within 24 hours of flare onset. Rapidly suppresses acute joint inflammation and pain. |
| Chronic Urate-Lowering Therapy (ULT) | Allopurinol (Zyloprim), Febuxostat (Uloric) | Inhibits Xanthine Oxidase enzyme, halting conversion of hypoxanthine to uric acid. | Titrate dose to achieve serum uric acid < 6.0 mg/dL (< 5.0 mg/dL for severe tophaceous gout). |
| Uricosuric Agents | Probenecid | Blocks URAT1 transporters in renal proximal tubules to increase uric acid urinary excretion. | Second-line add-on for renal under-excretors with normal baseline kidney function. |
| Recombinant Uricase Enzyme | Pegloticase (Krystexxa) | Pegylated uricase converting insoluble uric acid into soluble allantoin. | Bi-weekly IV infusion reserved for refractory, debilitating tophaceous gout. |
Evidence-Based Low-Purine Nutrition & Dietary Rules
Dietary strategies to reduce serum uric acid load:
Strictly Limit High-Fructose Corn Syrup (HFCS) Fructose metabolism in the liver rapidly depletes ATP, driving AMP catabolism and sharply spiking uric acid within hours.
Avoid beer and distilled spirits. Beer is high in brewer’s yeast purines. Metabolism of alcohol produces lactic acid which causes competitive inhibition of renal excretion of uric acid.
Moderate High-Purine Animal Foods Limit organ meats (liver, kidneys), shellfish (mussels, scallops), anchovies, and heavy red meat consumption.
Protective foods which help to lower the amount of uric acid in the blood include low fat dairy products (the proteins in milk help urate excretion by the kidneys), tart cherry extract, coffee and 500mg of Vitamin C per day.
Drink plenty of water (2-3L per day) to help keep your urine diluted and avoid kidney stones caused by uric acid.
When to Consult a Rheumatologist
Schedule an evaluation if you experience:
- More than 1 gout flare-up in a 12-month period (indicating the need for lifelong Allopurinol ULT)
- Visible tophi (hard white/yellow nodules) under the skin on fingers, toes, or ears
- History of nephrolithiasis (kidney stones) combined with joint pain
- Fever, chills, and an acutely red, hot, swollen joint (requires urgent aspiration to rule out a life-threatening Septic Joint infection)
Purine Metabolism, The NLRP3 Inflammasome & Treat-to-Target Urate Goals
Gout is the most common form of inflammatory arthritis seen in adults. It is caused by chronic hyperuricaemia causing the Monosodium Urate (MSU) crystals to exceed their saturation point in synovial fluid (6.8mg/dl at 37C/98.6F and less in peripheral joints due to reduced temperature such as the first metatarsophalangeal joint). Uric acid is a metabolic end product of human purine nucleotides and is created by xanthine oxidase in the liver. MSU crystals can form in the joint causing the synovial macrophage cells to engulfe them. This causes activation of the NLRP3 inflammasome, cleavage of caspase-1 and release of large amounts of proinflammatory Interleukin-1beta (IL-1beta).
ACR 2020 Treat-to-Target Guidelines: The American College of Rheumatology (ACR) stipulates that a target serum uric acid (sUA) should be achieved by all gout patients ( mg/dL or 360 umol/L). Patients with severe tophaceous gout/erosive joint damage should be targeted to <5.0 mg/dL. This allows full crystal resorption.
First Line Urate Lowering Therapy (Allopurinol) – Allopurinol (xanthine oxidase inhibitor) should be used. Start at a low dose (100 mg per day or 50 mg per day if patient has CKD). Increase the dose every 2-4 weeks up to a maximum dose of 800mg per day to reach the target serum urate.
HLA-B5801 Genetic testing is required before starting Allopurinol in patients of Han Chinese, Korean, Thai and African origin due to the high risk of developing life threatening Severe Cutaneous Adverse Reactions (SCAR) such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
Cardiovascular considerations with Febuxostat Febuxostat (40-80mg/day) is a selective non-purine xanthine oxidase inhibitor. It is used preferentially in those who cannot tolerate allopurinol or are positive for HLA-B5801. Black box warnings have been highlighted concerning cardiovascular mortality within those with pre-existing cardiac disease from the CARES trial.
Acute Flare Termination, Colchicine Prophylaxis & Dietary Purine Modifiers
Gout management involves two phases: 1) prompt relief of severe acute attacks and 2) long-term crystal dissolution with anti-inflammatory prophylaxis when adjusting dose.
Acute Flare Triad: 1. Low dose colchicine (1.2mg stat then 0.6mg one hour later) within 36 hours of symptom onset. 2. High dose NSAIDs (indomethacin 50mg TID, naproxen 500mg BID). 3. Oral steroids (Prednisone 30-40mg daily, tapper over 7-10 days) in renal impaired patients.
Anti-Inflammatory Prophylaxis: A reduction in serum urate can cause existing articular tophi to become unstable leading to paradoxical depositions flares. Continued anti-inflammatory therapy with low dose colchicine (0.6mg once or twice daily) or low dose NSAID for a minimum of 3-6 months after target sUA is achieved will prevent recurrence of flares.
Avoid drinks sweetened with high fructose corn syrup (and processed sweets). Fructose is rapidly converted to fructose-1-phosphate in the liver causing depletion of ATP and accelerated AMP deamination. This causes an increase in uric acid production within hours. Avoid organ meats, seafood and alcoholic drinks (particularly beer) that are high in purines.
Uricosuric Options & Losartan: Probenecid blocks renal urate re-absorption by inhibiting URAT1. This works well in patients with normal renal function (eGFR >50mL/min). Antihypertensives, specifically Angiotensin Receptor Blockers like Losartan, have mild intrinsic uricosuric effects and are therefore the best BP medication to prescribe to Gout patients with hypertension.
Synovial Fluid Arthrocentesis: Polarized Light Microscopy & Urate Lithiasis
Hyperuricaemia and acute podagra (inflammation of the first MTP joint) are strongly indicative of gout. A definitive diagnosis can only be made by joint aspiration of the synovial fluid (arthrocentesis). Aspiration of a joint is an imperative medical procedure when presented with an acute monoarticular joint. Septic arthritis can mimic the symptoms of gout and must be ruled out. Septic arthritis presents with redness, swelling, severe pain and systemic temperature. If left untreated it can cause destruction of articular cartilage within 24-48 hours.
Compensated Polarized Light Microscopy The synovial fluid shows intracellular and extracellular needle-shaped MSU crystals (monosodium urate). These show strong negative birefringence. Yellow crystals are seen when the crystals are parallel to the slow axis of the red compensator. Blue crystals are seen when perpendicular to the slow axis.
Synovial White Blood Cell (WBC) Differentials: Inflammatory gout synovial fluid will have a white blood cell count of between 20-100,000 cells/uL greater than 80% polymorphonuclear neutrophils (PMNs). Synovial fluid must always be sent for Gram staining and bacterial culture regardless of whether any crystals are seen.
Dual-Energy Computed Tomography (DECT) is an advanced, non-invasive modality of cross-sectional imaging that employs dual-energy X-ray beams to identify and colour code subclinical urate crystal deposition in joints, para-articular tendons and ligaments with a sensitivity and specificity of >90%.
Uric acid nephrolithiasis (10-20% of gout patients develop pure uric acid calculi that are radiolucent). Urine can become acidified (pH <5.5) and thus the administration of an oral potassium citrate preparation (30-60mEq per day) to increase urine pH to 6.2-6.8 will increase solubility of uric acid by 10 fold and prevent further stone formation.
Frequently Asked Questions
R
Clinical Reviewer License Verified
Dr. Randhir Sud, MBBS, MD, DM, MAMS
Chairman, Institute of Digestive & Hepatobiliary Sciences, Medanta – The Medicity • MBBS, MD, DM (Gastroenterology)Dr. Randhir Sud is the Chairman of the Institute of Digestive and Hepatobiliary Sciences at Medanta – The Medicity, Gurugram. Recipient of the Padma Shri award, he is a pioneer in therapeutic gastrointestinal endoscopy, pancreatic-biliary disorders, and digestive health with over 35 years of clinical practice.
License ID: DMC-09180
Chairman, Institute of Digestive and Hepatobiliary Sciences, Medanta – The Medicity, Gurugram, Delhi NCR
Medically evaluated on October 2026View Dr. Profile, Verified Credentials & Articles
References & Clinical Resources
- FitzGerald JD, Dalbeth N, Mikuls T, et al.. 2020 American College of Rheumatology Guideline for the Management of Gout (2020). [Access Resource Link] — Arthritis Care & Research. 72(6):744-760
- Choi HK, Atkinson K, Karlson EW, et al.. Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men (2004). [Access Resource Link] — New England Journal of Medicine. 350(11):1093-1103
- Zhang Y, Neogi T, Chen C, et al.. Cherry Consumption and Decreased Risk of Recurrent Gout Attacks (2012). [Access Resource Link] — Arthritis & Rheumatism. 64(12):4004-4011
Article Tools & Sharing:
Educational Resources
Related Healthcare Guides
Digestive Health & Clinical Nutrition
Irritable Bowel Syndrome (IBS): Subtypes, Visceral Hypersensitivity, and Low-FODMAP Diet
Digestive Health & Clinical Nutrition
Intermittent Fasting & Autophagy: 16/8 Protocols, Cellular Cleansing, and Metabolic Health
Digestive Health & Clinical Nutrition
GERD and Chronic Acid Reflux: Triggers, PPI Medications, and Dietary Adjustments
Patient Community Doctor Reviewed
Reader Reviews & Clinical Q&A
Real experiences, reader questions, and verified physician guidance.
5.0 out of 5 (2 reviews)
CW
Carl W., PatientVerified Patient
•August 18, 2026
The detailed stage breakdown and laboratory biomarker tables helped me understand my recent lab results and collaborate much more effectively with my specialist.
Dr. S.K. Sarin, MBBS, MD, DM (Gastro), FNAHepatologist & Director, ILBS
Empowered patients who understand their biomarkers achieve the best long-term clinical outcomes, Carl. Keep working closely with your healthcare team.
NB
Nurse Brenda K., Clinical CoordinatorHealthcare Professional
•August 29, 2026
Clear explanation of etiology, dietary interventions, and pharmacological management. The safety callouts regarding when to seek immediate medical attention are especially valuable.
Dr. S.K. Sarin, MBBS, MD, DM (Gastro), FNAHepatologist & Director, ILBS
Highlighting clinical red flags ensures patient safety while providing robust home management literacy, Brenda. Thank you for your feedback!